RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. Vensana Capital
V

Vensana Capital portfolio

Vensana Capital has 3 portfolio companies on record at Recent Funding. Its most recent investment on record is Personal Genome Diagnostics's $100M Series B+ round in February 2021, alongside Windham Venture Partners, Sands Capital Ventures, Rock Springs Capital and 6 others. By category, its portfolio leans toward Health and bio (3) and Data and analytics (1).

Type: Investor.
Portfolio on Recent Funding: 3.
Deals, last 12 months: 0.
Capital in their rounds: $100M.
Latest deal: Personal Genome Diagnostics · Feb 1, 2021.

What Vensana Capital invests in

How Vensana Capital invests

StageDealsCapital in rounds
Series B+ 1 100%$100M

Share is of the 1 round on Recent Funding that name Vensana Capital. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Vensana Capital portfolio companies

CompanyRound with Vensana CapitalTotal raisedLatest raise
PPersonal Genome Diagnostics
Health and bio
Series B+ · $100M$123.8MNov 24, 2025
Series B+
CCleerly
Health and bio
backer$106MJan 24, 2025
Series B+
LLuna Diabetes
Health and bio
backer$23.6MAug 18, 2025
Series A

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

Portfolio companies are the companies on Recent Funding with a round that lists Vensana Capital, which is a subset of its real portfolio. API: /api/v1/investors/vensana-capital (get a free API key). More: the most active VC firms and new venture capital funds.

Top raises, every week

The week's top funded startups and market insights, in your inbox every Monday.

Unsubscribe anytime · privacy